Towards identification of subsets of patients with multiple myeloma who benefit from high-dose chemotherapy. Haematologica 1999;84(10):867-868; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is required.
For information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
